From Raw Powder to Finished Tablet
The Production Pipeline
Full transparency at every stage — each raw powder is assayed, every formulation is dosed to a target, pressed, and independently lab-tested before it ships. This is exactly how our products are built, with the COA behind each one.
How it flows
Raw material → finished product
1
Raw Powder Assay
% active by weight, verified by Cora Science
→
2
Formulation Recipe
Dose to target via assay-driven scale factor
→
3
Sample Tablets Produced
Pressed to spec (powders ship as-is)
→
4
COA Test
PharmLabs San Diego potency verification
→
5
Reformulate
Only if a leg tests short — re-dose & re-test
→
6
Final Manufacture
Cora-safe potency, label claim holds
Straight-powder products skip compression (step 3) and are sold as powder. Step 5 only runs when a COA comes back short.
Inputs
Raw Input Powders
Assayed by Cora Science
ISO/IEC 17025
ISO/IEC 17025
Standard 7-OH Powder
Lot 251217-H · Tested May 29 2026
92.2%
7-hydroxy-
mitragynine
mitragynine
MGM-15 Powder
Lot G-260205-H
97.51%
mitragynine
(MGM)
(MGM)
Pseudo Powder
Lot C-260114-H
85.93%
mitragynine
pseudoindoxyl
pseudoindoxyl
Special Blend 69
Mitragynine
Lot 10004 · Sold as powder
69.1%
mitragynine
90.1% total alkaloids
90.1% total alkaloids
Output
Formulations In Production
Tablet samples tested by
PharmLabs San Diego · Jun 17 2026
PharmLabs San Diego · Jun 17 2026
Accepted
Blue Raspberry
7-OH80 mg#140907
Target 7-OH80.00 mg
Tested 7-OH78.83 mg
Tested as "Strawberry Watermelon 80." On-target at 78.83 mg vs 80 mg label. Light scale bump dials it in. Second-highest 7-OH per tablet after Big League Chewy's (93.29 mg). Cleared for manufacture.
Accepted
Passion Fruit MGM-15
MGM#140906
Target MGM15.00 mg
Tested MGM15.01 mg
Dead on-target. Cleared for manufacture as-is.
Reformulating
Citrus Mint 777
7-OHMGMPseudo#140905
7-OH tgt 77.23 mg
MGM tgt 76.65 mg
Pseudo tgt 74.15 mg
Pseudo leg ran ~41% short (59% recovery at 4.15 mg vs 7 mg target). 7-OH and MGM legs both on-target.
REFORMULATING → pseudo leg replaced by mitragynine via Special Blend 69. New target: 7 mg 7-OH + 7 mg MGM + 7 mg mitragynine (each built to 7.7 mg with overage). ~11.1 mg of SB69 powder per tablet for the mitragynine leg.
Accepted
Mixed Berry 20/20
7-OHMitragynine#140904
7-OH tgt 2021.31 mg
Mitragynine tgt 2015.31 mg
Speciociliatine2.30 mg
First dual-alkaloid formulation: 7-OH + mitragynine. 7-OH leg on-target; mitragynine leg slightly short of 20 mg target but within range. Speciociliatine detected as supporting alkaloid. Cleared for manufacture.
Needs Verification
Pseudo Tab
Strawberry Watermelon
Strawberry Watermelon
Pseudo10 mg
Label target10 mg
Built to (+ovg)11 mg
Ref (777 pseudo)4.15 mg @ 7 mg tgt
Based on 777 pseudo recovery (59%), needs ~2.6× the loading per mg of target (≈18.6 mg-equivalent input for 11 mg built-to). Verification batch required before full production.
COA pending verification batch
Discontinued
Grape Soda 40
7-OH#140908
Target 7-OH40.00 mg
Tested 7-OH39.18 mg
Tested on-target at 39.18 mg 7-OH per tablet. Not moving forward — flavor discontinued, formulation shelved.
Reference
COA Library
Standard 7-OH Powder · 251217-HPDF ↓
MGM-15 Powder · G-260205-HPDF ↓
Pseudo Powder · C-260114-HPDF ↓
Special Blend 69 · 10004PDF ↓
Blue Raspberry (tested as Strawberry Watermelon 80) · #140907PDF ↓
Passion Fruit MGM-15 · #140906PDF ↓
Citrus Mint 777 · #140905PDF ↓
Mixed Berry 20/20 · #140904PDF ↓
Grape Soda 40 · #140908 (discontinued)PDF ↓
Raw powders verified by Cora Science (ISO/IEC 17025). Finished tablet samples tested by PharmLabs San Diego.
Every formulation is dosed from its raw-powder assay, lab-tested for potency, and reformulated if any active runs short before full manufacture.